@article{d6008d2e939a42529e765a9f9031148c,
title = "Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group",
keywords = "atopic dermatitis, biologic therapy, consensus recommendations, cutaneous T-cell lymphoma, diagnostic delay, Dupilumab, mycosis fungoides, S{\'e}zary syndrome",
author = "Joana Calv{\~a}o and \{de Masson\}, Ad{\`e}le and Antonio Cozzio and Chalid Assaf and Constanze Jonak and Emmilia Hodak and Evangelia Papadavid and Gabriele Roccuzzo and Nicolay, \{Jan Peter\} and Julia Scarisbrick and Vermeer, \{Maarten H.\} and Martine Bagot and Maxime Battistella and Ortiz-Romero, \{Pablo Luis\} and Patrick Brunner and Pietro Quaglino and Richard Cowan and Rudolf Stadler and Werner Kempf and Margarida Gon{\c c}alo and Emmanuella Guenova",
note = "Publisher Copyright: {\textcopyright} 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma \& Immunology. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/",
year = "2026",
month = jun,
doi = "10.1016/j.jaci.2026.04.002",
language = "English",
volume = "157",
pages = "1237--1245",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
number = "6",
}
SDG 3 Good Health and Well-being